Get access

Introduction to “Screening for Endocrine Activity—Experiences with the US EPA's Endocrine Disruptor Screening Program and Future Considerations”

Authors

  • Sue Marty

    Corresponding author
    1. Toxicology & Environmental Research and Consulting, The Dow Chemical Company, Midland, Michigan
    • Correspondence to: Dr. Sue Marty, The Dow Chemical Company, 1803 Building, Midland, MI 48674. E-mail: mmarty@dow.com

    Search for more papers by this author

No abstract is available for this article.

Ancillary